Ruijian Biotech

瑞健生物

Ruijian Biotech

Biotech/Healthcare

Ruijian Bio develops drugs for neurological and psychiatric disorders, with a focus on first-in-class and best-in-class therapies. It operates three technology platforms covering key challenges in CNS drug development: a protein–protein interaction analysis platform, a cell-penetrating peptide/PDC…

Latest round: Angel (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-07-01